Türk Medline
ADR Yönetimi
ADR Yönetimi

FORMULATION AND IN VIVO PHARMACODYNAMICS STUDIES OF NANOSTRUCTURED LIPID CARRIERS FOR TOPICAL DELIVERY OF BIFONAZOLE RUNNING HEAD: NANOSTRUCTURED LIPID CARRIERS AS VESICLES FOR TOPICAL DELIVERY OF BIFONAZOLE

AMAN DEEP, MANİSH KUMAR, RAKESH PAHWA, SUMEET GUPTA, SHAİLENDRA BHATT, BEENA KUMARİ, PRABHAT KUMAR UPADHYAY, A PANDURANGAN

Acta Pharmaceutica Sciencia - 2021;59(1):559-580

M.M College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, India

 

The main objective of the present study was to developed and evaluated the Bifonazole (BFZ) loaded Nanostructured lipid carriers (NLCs) for topical delivery of BFZ. BFZ-NLCs were deve560ted for Particle size, EE, DL and drug release profiles. The invitro release studies show better drug release over 24h as compared to the marketed formulation. Ex-vivo skin permeation and Pharmacodynamic studies indicated that NLCs get effectively reduced the fungal infection. In-vitro antifungal activity study shows that the BFZ-NLCs were more effective in inhibiting the growth of Candida Albicans. Therefore, the study concludes that NLCs showed a continuous release profile and has the prospective for treatment of topical fungal infections.